Evaluation of The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01582022|
Recruitment Status : Unknown
Verified April 2012 by Abdulmalik S. Alsaied, King Saud University.
Recruitment status was: Not yet recruiting
First Posted : April 20, 2012
Last Update Posted : April 20, 2012
It will be a prospective, randomized, placebo-controlled, single-blind, intra-individual study in which one tonsillar fossa will be the tested side, and the other fossa will be the control. And the tested side will be packed with bupivacaine for five minutes. In the other hand, the controlled side will be packed for five minutes with gauze soaked in normal saline. The selection of the tested side and controlled side will be randomized based on the last digit in the medical record number (i.e. if the last digit is even then the tested side is the right and if the last digit is odd then the tested side is the left). Pain evaluation will be by visual analog scale and it will be in frequency of 2, 4, 6, 8, 12, 24 hours post-op.
|Condition or disease||Intervention/treatment||Phase|
|Tonsillectomy||Drug: Bupivacaine Drug: normal saline||Phase 4|
Evaluation of The Effect of Bupivacaine (marcaine) in Reducing Early Post Tonsillectomy Pain (Prospective, randomized, intra-individual study.) Study guidelines
Aim of the study
- to evaluate the effectiveness of applying bupivacaine intra-operative in reducing early post-tonsillectomy pain
Patients and methods
- It will be a randomized, placebo-controlled, single-blinded study
- one tonsillar fossa will be the tested side, and the other fossa will be the control
- to insure the random selection, the tested and control sides will be selected based on unpredicted method e.g. based on the last number in pt MRN: If the last # is even (0, 2, 4, 6, 8) = right side will be the tested If the last # is odd (1, 3, 5, 7, 9) = left side will be the tested
Exclusion criteria included :
- pt with past history of unilateral peritonsillar abscess
- the current, regular use of a systemic steroid or NSAID
- a known hypersensitivity to bupivacaine
- a combined with unilateral myringotomy or bilateral myringotomy with unilateral ventilation tube
- pt with poor dental hygiene
- accompanied adenoidectomy is not an exclusion criteria
- the tested side will be : packed (after classic tonsillectomy) with gauze soaked in 0.5% bupivacaine, (2ml of bupivacaine + 2ml NS)for 5 min.
- the control side will undergoing the same of tested side but with normal saline
- post-operative analgesia will be paracetamol
- pain evaluation will be by visual analog scale (fig. 1) and it will be in frequency of 2, 4, 6, 8, 12, 24 hours post-op (frequency can be re-adjusted)
- Data of pain will be collected by the nurse. And they will not know which side is the tested. (single- blind)
- after phase I (data collection). Data will be calculated for P-value and other statistics scores
- Targeted sample size is 35 patients.
- patients will be consented for the possible adverse reactions of local application of the tested medicine (e.g. allergic reactions, Paresthesia). However, because in our study we will not add adrenaline, so differences in incidence of post-tonsillectomy bleeding is not expected.
- data will be statistically analyzed by McNemar's test
- For the data safety monitoring of the study, an independent external otolaryngology consultant (Dr.Ahmed Alarfij) will be assigned to monitor the safety of study participants.
|Study Type :||Interventional (Clinical Trial)|
|Primary Purpose:||Supportive Care|
|Official Title:||The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain|
Experimental: local anesthetic
local anesthetic agent
local application for 5 minutes
Other Name: marcaine
Placebo Comparator: normal saline
Drug: normal saline
local application for 5 minutes
Other Name: comparator
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01582022
|Contact: abdulmalik s alsaied, email@example.com|